Cigna Group (NYSE:CI) Given Consensus Rating of "Moderate Buy" by Brokerages

Key Points

• Cigna Group has a consensus analyst rating of “Moderate Buy” from 21 covering firms, with an average 12-month price target of $339.50.
• The company beat earnings and revenue estimates in its latest quarter, reporting EPS of $7.79 versus the $7.60 consensus and revenue of $68.52 billion versus $66.29 billion expected.
• Cigna also announced a quarterly dividend of $1.56 per share, or $6.24 annually, which implies a 2.2% yield.

Shares of Cigna Group (NYSE:CI - Get Free Report) have earned an average recommendation of "Moderate Buy" from the twenty-one ratings firms that are currently covering the company, MarketBeat reports. Six equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $339.50.

CI has been the topic of a number of research reports. TD Cowen upped their target price on Cigna Group from $333.00 to $338.00 and gave the company a "buy" rating in a report on Monday, February 9th. Cantor Fitzgerald upped their target price on Cigna Group from $325.00 to $340.00 and gave the company an "overweight" rating in a report on Friday, May 1st. Guggenheim upped their target price on Cigna Group from $334.00 to $338.00 and gave the company a "buy" rating in a report on Monday, May 4th. Deutsche Bank Aktiengesellschaft downgraded Cigna Group from a "buy" rating to a "hold" rating and dropped their target price for the company from $303.00 to $302.00 in a report on Wednesday, May 20th. Finally, Robert W. Baird set a $337.00 target price on Cigna Group in a report on Friday, May 1st.

Cigna Group Price Performance

NYSE CI opened at $285.80 on Thursday. The stock's 50-day moving average price is $277.65 and its two-hundred day moving average price is $276.73. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.69. The company has a market cap of $75.60 billion, a PE ratio of 12.12, a PEG ratio of 1.01 and a beta of 0.30. Cigna Group has a 1 year low of $239.51 and a 1 year high of $338.89.

Cigna Group (NYSE:CI - Get Free Report) last issued its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, beating analysts' consensus estimates of $7.60 by $0.19. The company had revenue of $68.52 billion for the quarter, compared to the consensus estimate of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The firm's quarterly revenue was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, analysts predict that Cigna Group will post 30.39 EPS for the current year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Investors of record on Thursday, June 4th will be paid a $1.56 dividend. The ex-dividend date of this dividend is Thursday, June 4th. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. Cigna Group's payout ratio is presently 26.45%.

Insider Activity at Cigna Group

In related news, insider Everett Neville sold 1,719 shares of the business's stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $496,636.29. Following the completion of the sale, the insider owned 5,670 shares of the company's stock, valued at approximately $1,638,119.70. The trade was a 23.26% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO David Cordani sold 201,878 shares of the business's stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the sale, the chief executive officer directly owned 34,337 shares of the company's stock, valued at approximately $10,054,560.34. The trade was a 85.46% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 205,904 shares of company stock valued at $60,277,068. 0.60% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Cigna Group

Large investors have recently made changes to their positions in the company. Wilkerson Advisory Group LLC bought a new stake in shares of Cigna Group in the 4th quarter valued at approximately $25,000. Beacon Financial Strategies CORP bought a new stake in shares of Cigna Group in the 4th quarter valued at approximately $28,000. Cedar Mountain Advisors LLC grew its stake in shares of Cigna Group by 161.9% in the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider's stock valued at $29,000 after buying an additional 68 shares in the last quarter. Kemnay Advisory Services Inc. bought a new stake in shares of Cigna Group in the 4th quarter valued at approximately $29,000. Finally, Prosperity Bancshares Inc bought a new stake in shares of Cigna Group in the 4th quarter valued at approximately $29,000. Institutional investors own 86.99% of the company's stock.

About Cigna Group

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.